SLU-PP-332 is NOT a peptide, it's a synthetic small molecule (~290 Da), a pan-ERR (estrogen-related receptor) agonist with preference for ERRα, developed at Saint Louis University as an 'exercise mimetic'.
SLU-PP-332 Prices
20 vendors · 7 with an issuer-verified COA · lowest 10mg from $41.40 · checked
Where to buy SLU-PP-332: 20 vendors compared
| Vendor | Price | Actions |
|---|---|---|
| 7-test panelVerified COAKovera Labs · Tested Aug 3, 2026 | $41.40 | Buy SLU-PP-332 from Lost Coast Aminos |
| 7-test panelVerified COAKovera Labs · Tested May 26, 2026 | $67.48 | Buy SLU-PP-332 from Glacier Aminos |
| 3-test panelVerified COAFreedom Diagnostics | $76.21 | Buy SLU-PP-332 from Hacker Peptides |
| 5-test panelVerified COAFreedom Diagnostics | $76.25 | Buy SLU-PP-332 from PeakForce Labs |
| $76.49 | Buy SLU-PP-332 from MS Peptides | |
| $76.50 | Buy SLU-PP-332 from Upgrade Bio Labs | |
| $79.202 × 5mg packages · 10mg totalChecked today | Buy SLU-PP-332 from Corix Labs | |
| 5-test panelVerified COAFreedom Diagnostics | $81.00 | Buy SLU-PP-332 from Novaglo Research |
| $89.0010mg packageChecked today | Buy SLU-PP-332 from True Research Labs | |
| $90.8910mg packageChecked today | Buy SLU-PP-332 from Northline Labs | |
| 3-test panelVerified COAFreedom Diagnostics | $127.48 | Buy SLU-PP-332 from Rivn Peptides |
| $127.48 | Buy SLU-PP-332 from SomaChems | |
| $131.98 | Buy SLU-PP-332 from Swift Peptides | |
| $135.00 | Buy SLU-PP-332 from Athena Peptides | |
| $140.00 | Buy SLU-PP-332 from VAYN | |
| $144.00 | Buy SLU-PP-332 from Peptides Costa Rica | |
| $150.002 × 5mg packages · 10mg totalChecked today | Buy SLU-PP-332 from Elite RX Labs | |
| $153.522 × 5mg packages · 10mg totalChecked today | Buy SLU-PP-332 from Ultima Life | |
| $160.20 | Buy SLU-PP-332 from Nurish Labs | |
| 2-test panelVerified COACanada Peptide Testing · Tested Sep 29, 2026 | $213.982 × 5mg packages · 10mg totalChecked today | Buy SLU-PP-332 from Cellugenix Peptides |
Tracked every day
SLU-PP-332 listing prices, tracked daily
The five cheapest in-stock package prices for SLU-PP-332 on each collected day, and the vendors that most often held those places.
Five cheapest in-stock package prices per day
Listed package price before coupons, any vial size. This is not the coupon-adjusted lowest 10mg price used to rank the comparison.
- Cheapest$18.00
- 2nd cheapest$35.00
- 3rd cheapest$37.49
- 4th cheapest$39.60
- 5th cheapest$44.85
Vendors most often in the cheapest five
- VAYN22 days$35.00+100.0%
- Glacier Aminos22 days$37.49-6.3%
- Lost Coast Aminos20 days$46.00last seen Oct 9, 2026-8.0%
- PeakForce Labs16 days$44.85-35.0%
- Amino Vault14 days$64.60last seen Oct 5, 20260.0%
- Novaglo Research4 days$18.000.0%
- Corix Labs3 days$39.600.0%
- Elite RX Labs3 days$75.00last seen Oct 6, 2026+36.4%
Top 8 of 9 vendors that reached the cheapest five
Current market data
SLU-PP-332 Price Report
A current summary of public listings after the price comparison above. Shipping and tax are not included.
The lowest current 10mg cost for SLU-PP-332 is $41.40 from Lost Coast Aminos. The median across vendors is $109.19.
- Lowest 10mg cost
- $41.40Lost Coast Aminos
- Median 10mg cost
- $109.19One normalized offer per vendor
- Lowest package total
- $16.20Novaglo Research · package size may differ
- Public COA coverage
- 100%20 of 20 vendors
What the market shows
PeptidePrices found 21 in-stock listings from 20 vendors, checked through Oct 10, 2026. The lowest 10mg cost is 62% below the vendor median of $109.19; 10 vendors (50%) fall below that median. 20 of 20 vendors (100%) publish public COA evidence.
A public COA link shows that a vendor publishes testing data. It does not prove that every listed vial has a matching current report. Match the product, strength, batch, and lot before relying on a report.
How this report is calculated
The headline and median use each vendor's lowest whole-package checkout cost to obtain at least 10mg. Smaller packages are multiplied until the target is met, while larger packages retain their full checkout price. The lowest package total is shown only as secondary context because package sizes differ. Known public coupon discounts are applied. Shipping, tax, and unverified promotions are excluded.
Research context
What is SLU-PP-332? Research, safety, and status
SLU-PP-332 is an experimental 'exercise mimetic', a small molecule that switches on the metabolic gene programs normally triggered by aerobic exercise. In obese and aging mice it drives weight loss, raises energy expenditure, and improves endurance without the animals exercising more or eating less.
Key research takeaways
SLU-PP-332 at a glance
PeptidePrices safety rating
4/10 · Not FDA-approved (never tested in humans)
Mechanism
Potent synthetic agonist of estrogen-related receptors α, β, and γ (ERRα/β/γ); activates mitochondrial biogenesis; enhances oxidative metabolism in muscle; mimics exercise adaptations.
Research areas
Exercise mimetic (dubbed 'exercise in a pill'); endurance enhancement; metabolic health; mitochondrial biogenesis; potential heart failure treatment; anti-obesity.
Regulatory / research status
Research / preclinical only
Half-life
Not well-established in humans.
Storage
Lyophilized vial: store at -20°C long-term or 2-8°C short-term, protected from light.
Reported side effects
Insufficient human data. Theoretical: hormonal disruption (ERR signaling), cardiovascular effects. Promising safety in animal studies.
Small-molecule ERR agonist, NOT a peptide. Never administered to a human, no trials, no human dose, human safety completely unknown. Animal safety was favorable, but the rating reflects zero human exposure. Lab reagent (DMSO-soluble). Safety ratings summarize published clinical data, adverse-event reporting, and regulatory status. How PeptidePrices rates evidence. Research information only, not medical advice.
Study highlights
- SLU-PP-332 is a first-in-class synthetic pan-ERR agonist (ERRα EC50 = 98 nM, ERRβ 230 nM, ERRγ 430 nM) developed at Saint Louis University; in mice, 28-day administration increased type IIa oxidative skeletal muscle fibers and boosted treadmill endurance by ~70% in distance and ~45% in duration, effects shown to be ERRα-dependent via muscle-specific knockout validation.
- Mechanistically, SLU-PP-332 stabilizes the ERRα active conformation and recruits PGC-1α, inducing a transcriptional program overlapping with acute aerobic exercise, particularly upregulating mitochondrial biogenesis, fatty acid oxidation, and oxidative phosphorylation genes without requiring physical activity.
- In diet-induced obese and ob/ob mouse models, SLU-PP-332 increased resting energy expenditure and fatty acid oxidation (~25% above controls), decreased fat mass accumulation, improved glucose tolerance, and reduced hepatic steatosis and liver triglycerides, supporting therapeutic potential for metabolic syndrome.
- All current evidence for SLU-PP-332 is preclinical (mouse models only, 2023-2024); no human clinical trials have been initiated as of 2026. Translation to humans, long-term safety, and pharmacokinetic suitability remain unestablished.
Selected references
- Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity · ACS Chem Biol / PMC, 2023
- A Synthetic ERR Agonist Alleviates Metabolic Syndrome · J Pharmacol Exp Ther / PMC, 2024
- A Synthetic ERRα Agonist Induces an Acute Aerobic Exercise Response and Enhances Exercise Capacity (Preprint) · bioRxiv, 2022
Related pages